O Levels Biology (5090)•5090/12/O/N/22

Explanation
Recombinant insulin production benefits
Steps:
- Identify the process: Human insulin gene is inserted into bacteria, which replicate and produce insulin in large quantities.
- Compare to animal insulin: Animal sources are limited by slaughter and extraction, while bacteria enable mass production.
- Evaluate advantages: Focus on availability, purity, and scalability for patient use.
- Eliminate misconceptions: Rule out genetic transfer or physiological changes in patients.
Why C is correct:
- Bacterial cultures allow unlimited, cost-effective scaling via fermentation, ensuring consistent supply unlike finite animal sources.
Why the others are wrong:
- A: Insulin therapy treats symptoms but does not alter or pass on diabetes genes.
- B: Exogenous insulin replaces missing production but does not restore pancreatic function.
- D: Administered insulin is a protein, not a gene, so no DNA transfer occurs to patients.
Final answer: C
Topic: Genetic modification
Practice more O Levels Biology (5090) questions on mMCQ.me